DexCom Inc (DXCM)

85.13
NASDAQ : Health Care
Prev Close 85.13
Day Low/High 0.00 / 0.00
52 Wk Low/High 47.92 / 96.38
Avg Volume 1.49M
Exchange NASDAQ
Shares Outstanding 84.52M
Market Cap 7.20B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Short Interest In DexCom Decreases By 14%

Short Interest In DexCom Decreases By 14%

The most recent short interest data has been released for the 12/30/2016 settlement date, which shows a 1,165,825 share decrease in total short interest for DexCom Inc , to 7,210,719, a decrease of 13.92% since 12/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

DexCom: Look, but Don't Touch

DexCom: Look, but Don't Touch

The medical device company has been trading sideways for a long time and is likely to continue in the manner.

DexCom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2016 And Provides Initial 2017 Outlook

DexCom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2016 And Provides Initial 2017 Outlook

DexCom, Inc. (Nasdaq: DXCM) today reported that it achieved preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended December 31, 2016, an estimated increase of 28% over the fourth quarter...

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.

FDA Approval Of Dexcom's Non-Adjunctive Indication Triggers A New Era In Diabetes Management

FDA Approval Of Dexcom's Non-Adjunctive Indication Triggers A New Era In Diabetes Management

Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.

Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

Here are Monday's top research calls, including upgrades for Bristol-Myers Squibb and United Technologies, and a downgrade for Merck.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President and Chief Executive Officer, will present an...

Short Interest In DexCom Jumps 20.4%

Short Interest In DexCom Jumps 20.4%

The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 1,271,741 share increase in total short interest for DexCom Inc , to 7,504,789, an increase of 20.40% since 11/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...

Dexcom And Major League Soccer AT&T Rookie Of The Year Jordan Morris Kick-off Partnership To Help Those Living With Diabetes

Dexcom And Major League Soccer AT&T Rookie Of The Year Jordan Morris Kick-off Partnership To Help Those Living With Diabetes

Morris Has a New Goal to Share His Story of Becoming a Professional Athlete with Type 1 Diabetes in Hopes of Inspiring Others to Pursue Their Dreams Despite the Diagnosis

(Graphic: Business Wire)

(Graphic: Business Wire)

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

DexCom, Inc. Reports Third Quarter 2016 Financial Results

DexCom, Inc. Reports Third Quarter 2016 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2016.

Analysts' Actions -- Chevron, Home Depot, Macy's, Nike and More

Analysts' Actions -- Chevron, Home Depot, Macy's, Nike and More

Here are Monday's top research calls, including upgrades for Chevron, Macy's and Qualcomm, and downgrades for Home Depot, Lowe's, Exxon Mobil, Nike and Nordstrom.

NXPI, AAPL, C: Jim Cramer's Views

NXPI, AAPL, C: Jim Cramer's Views

Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.

4 Short Stock Trades You Should Be Watching

4 Short Stock Trades You Should Be Watching

Here are four stocks that are trending lower in this precarious market.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Actor Derek Theler And Dexcom Take Center Stage To Raise Awareness Of Diabetes

Actor Derek Theler And Dexcom Take Center Stage To Raise Awareness Of Diabetes

Theler, of Freeform TV's "Baby Daddy," Has Type 1 Diabetes and is Sharing His Success with Life-Changing Continuous Glucose Monitoring

DexCom Announces Upcoming Conference Presentations

DexCom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Kevin Sayer, President and Chief Executive Officer, will present an...

DexCom Schedules Third Quarter 2016 Earnings Release And Conference Call For November 1, 2016 At 4:30 P.m. Eastern Time

DexCom Schedules Third Quarter 2016 Earnings Release And Conference Call For November 1, 2016 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2016 financial results after market close on Tuesday, November 1, 2016.

Reimbursement Of Dexcom CGM Technology For Patients With Type 1 And Type 2 Insulin-Dependent Diabetes Is Now Available In Germany

Reimbursement Of Dexcom CGM Technology For Patients With Type 1 And Type 2 Insulin-Dependent Diabetes Is Now Available In Germany

Dexcom's Life-Changing Mobile CGM Technology for Diabetes Management Now a Covered Benefit for Patients with Diabetes in Germany

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Matt Dolan, Senior Director of Corporate Affairs, will present an...

DexCom Launches New Clinic Portal For The DexCom CLARITY® Diabetes Management Solution

DexCom Launches New Clinic Portal For The DexCom CLARITY® Diabetes Management Solution

New Features Enhance Continuous Glucose Monitoring Data and Insights Sharing Between Physicians and Patients

Jim Cramer's Top Takeaways: Johnson Controls, DexCom

Jim Cramer's Top Takeaways: Johnson Controls, DexCom

Cramer says Johnson Controls has a number of catalysts going for it starting with its forthcoming split into three companies.

Jim Cramer's 'Mad Money' Recap: Whoever Uses the Internet Best, Wins

Jim Cramer's 'Mad Money' Recap: Whoever Uses the Internet Best, Wins

The Internet is a beast. If you don't feed it, it will eat you alive, Cramer says.